NMDA receptor pathways as drug targets
- PMID:12403981
- DOI: 10.1038/nn936
NMDA receptor pathways as drug targets
Abstract
Since the mid 1980s, there has been a great deal of enthusiasm within both academia and industry about the therapeutic potential of drugs targeting the NMDA subtype of glutamate receptors. That early promise is just beginning to translate into approvable drugs. Here we review the reasons for this slow progress and critically assess the future prospects for drugs that act on NMDA receptor pathways, including potential treatments for some major disorders such as stroke and Alzheimer's disease, for which effective therapies are still lacking.
Similar articles
- Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease.Benarroch EE.Benarroch EE.Neurology. 2008 Mar 18;70(12):964-8. doi: 10.1212/01.wnl.0000306315.03021.2a.Neurology. 2008.PMID:18347319Review.No abstract available.
- 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA.Karanian DA, et al.Hippocampus. 2006;16(10):834-42. doi: 10.1002/hipo.20214.Hippocampus. 2006.PMID:16897723
- Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.Ritzén A, Mathiesen JM, Thomsen C.Ritzén A, et al.Basic Clin Pharmacol Toxicol. 2005 Oct;97(4):202-13. doi: 10.1111/j.1742-7843.2005.pto_156.x.Basic Clin Pharmacol Toxicol. 2005.PMID:16176554Review.
- Mechanism of action of memantine.Johnson JW, Kotermanski SE.Johnson JW, et al.Curr Opin Pharmacol. 2006 Feb;6(1):61-7. doi: 10.1016/j.coph.2005.09.007. Epub 2005 Dec 20.Curr Opin Pharmacol. 2006.PMID:16368266Review.
- The chemical biology of clinically tolerated NMDA receptor antagonists.Chen HS, Lipton SA.Chen HS, et al.J Neurochem. 2006 Jun;97(6):1611-26. doi: 10.1111/j.1471-4159.2006.03991.x.J Neurochem. 2006.PMID:16805772Review.
Cited by
- Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity.Zhou X, Ding Q, Chen Z, Yun H, Wang H.Zhou X, et al.J Biol Chem. 2013 Aug 16;288(33):24151-9. doi: 10.1074/jbc.M113.482000. Epub 2013 Jul 9.J Biol Chem. 2013.PMID:23839940Free PMC article.
- Upregulation of protein phosphatase 2A and NR3A-pleiotropic effect of simvastatin on ischemic stroke rats.Zhu M, Wang J, Liu M, Du D, Xia C, Shen L, Zhu D.Zhu M, et al.PLoS One. 2012;7(12):e51552. doi: 10.1371/journal.pone.0051552. Epub 2012 Dec 10.PLoS One. 2012.PMID:23251573Free PMC article.
- Serine 707 of APPL1 is Critical for the Synaptic NMDA Receptor-Mediated Akt Phosphorylation Signaling Pathway.Wang J, Lu W, Chen L, Zhang P, Qian T, Cao W, Luo J.Wang J, et al.Neurosci Bull. 2016 Aug;32(4):323-30. doi: 10.1007/s12264-016-0042-9. Epub 2016 Jun 14.Neurosci Bull. 2016.PMID:27300007Free PMC article.
- Increased Kv1 channel expression may contribute to decreased sIPSC frequency following chronic inhibition of NR2B-containing NMDAR.He S, Shao LR, Rittase WB, Bausch SB.He S, et al.Neuropsychopharmacology. 2012 May;37(6):1338-56. doi: 10.1038/npp.2011.320. Epub 2012 Jan 4.Neuropsychopharmacology. 2012.PMID:22218089Free PMC article.
- Synthesis and Biological Evaluation of Enantiomerically Pure (R)- and (S)-[18F]OF-NB1 for Imaging the GluN2B Subunit-Containing NMDA receptors.Korff M, Chaudhary A, Li Y, Zhou X, Zhao C, Rong J, Chen J, Xiao Z, Elghazawy NH, Sippl W, Davenport AT, Daunais JB, Wang L, Abate C, Ahmed H, Crowe R, Liang SH, Ametamey SM, Wünsch B, Haider A.Korff M, et al.Res Sq [Preprint]. 2023 Jan 27:rs.3.rs-2516002. doi: 10.21203/rs.3.rs-2516002/v1.Res Sq. 2023.Update in:J Med Chem. 2023 Dec 14;66(23):16018-16031. doi: 10.1021/acs.jmedchem.3c01441.PMID:36747738Free PMC article.Updated.Preprint.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical